luxscan 10k d microarray chip scanner (Jingxin Pharmaceutical Co Ltd)
86
Structured Review
Jingxin Pharmaceutical Co Ltd
luxscan 10k d microarray chip scanner
Luxscan 10k D Microarray Chip Scanner, supplied by Jingxin Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luxscan-10k+microarray+scanner/10k+chip+d+luxscan+microarray+scanner/pm41564508-47-25-47
Average 86 stars, based on 1 article reviews
Luxscan 10k D Microarray Chip Scanner, supplied by Jingxin Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luxscan-10k+microarray+scanner/10k+chip+d+luxscan+microarray+scanner/pm41564508-47-25-47
Average 86 stars, based on 1 article reviews
luxscan 10k d microarray chip scanner - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
other:Article Title: Application of Genetic Deafness Gene Chip for Detection of Gene Mutation of Deafness in Pregnant Women Article Snippet: Scanning and interpretation of the results: he chip was imaged with a Microarray:Article Title: Genetic screening for hearing impairment and the genotype-phenotype correlation of GJB2 c.109G>A variants in 47,729 neonates: a population-based study in southern China. Article Snippet: Background: This study aimed to characterize the Variant profile of the 4 common deafness-causing genes and evaluated the genotype-phenotype correlation of GJB2 c.109G > A variants in a neonatal cohort, providing insights for early diagnosis of congenital hearing loss.. Methods: A total of 47,729 newborns in Shenzhen underwent integrated deafness gene screening (23 common pathogenic variants across GJB2, SLC26A4, MT-RNR1, and GJB3) and two-stage audiometric assessments from January 2022 to November 2024.. Participants were stratified into three groups based on GJB2 c.109G > A genotypes: homozygous (Group A, n = 487), compound heterozygous (Group B, n = 87), and heterozygous carriers (Group C, n = 8055). Electrophoresis:Article Title: Genetic screening for hearing impairment and the genotype-phenotype correlation of GJB2 c.109G>A variants in 47,729 neonates: a population-based study in southern China. Article Snippet: Background: This study aimed to characterize the Variant profile of the 4 common deafness-causing genes and evaluated the genotype-phenotype correlation of GJB2 c.109G > A variants in a neonatal cohort, providing insights for early diagnosis of congenital hearing loss.. Methods: A total of 47,729 newborns in Shenzhen underwent integrated deafness gene screening (23 common pathogenic variants across GJB2, SLC26A4, MT-RNR1, and GJB3) and two-stage audiometric assessments from January 2022 to November 2024.. Participants were stratified into three groups based on GJB2 c.109G > A genotypes: homozygous (Group A, n = 487), compound heterozygous (Group B, n = 87), and heterozygous carriers (Group C, n = 8055). |
